Work

Abstract LB433: RW-108, a first-in-class adenosine A2 receptor inverse agonist for treating late-stage triple negative breast cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb433

Authors: Jean Jiang, Manuel Riquelme, Johanna Webb

Institution: The University of Texas at San Antonio Health Science Center

Language: English

Topic: Adenosine and Purinergic Signaling

Subfield: Physiology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409820962

Cites:

Cited by:

Related to: 10